An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

EVALUATION OF REPRODUCTIVE PARAMETERS AND EMBRYO DEVELOPMENT IN BEEF HEIFERS SUPPLEMENTED RUMEN UNDEGRADABLE PROTEIN

Objective

The PD aims to improve the beef industry by improving heifer development programs and increase cow longevity. Another goal of this project is to better understand the physiological effects of supplementing rumen undegradable protein to heifers during the development period. The PD aims to determine the source of rumen undegradable protein influences ovarian development, oocyte competence, embryo development, and uterine histotroph in beef heifers.Objective 1: To measure oocyte competence and embryo development in heifers supplemented varying levels and sources of rumen undegradable protein in a dry-lot setting. The PD will measure this objective by investigating the number of cumulus oocyte complexes recovered, number of embryos developing normally, and number of embryos that develop to a blastocyst stage amongst treatments.Objective 2: To measure amino acid concentrations in the uterine histrotroph and embryo development in heifers supplemented varying levels and sources of rumen undegradable protein in a dry-lot setting. The PD will measure this objective by investigating amino acid concentrations in the uterine histotroph and by the number of embryos that develop to a hatched blastocyst stage amongst treatments.Objective 3: To measure oocyte competence and embryo development in heifers supplemented varying levels and sources of rumen undegradable protein on native rangelands. The PD will measure this objective by investigating the number of cumulus oocyte complexes recovered, number of embryos developing normally, and number of embryos that develop to a blastocyst stage amongst treatments.

Investigators
Andrews, T. N.
Institution
NEW MEXICO STATE UNIVERSITY
Start date
2023
End date
2025
Project number
NM2022-13398
Accession number
1030894